Dynogen Pharmaceuticals' Death

Dynogen Pharmaceuticals raised a round of funding on , . Investors include Dead.

Dynogen is a biopharmaceutical company developing drugs for gastrointestinal (GI) and genitourinary (GU) disorders, including irritable bowel syndrome (IBS) and overactive bladder (OAB). Dynogen focus…

Articles about Dynogen Pharmaceuticals' Death: